Keng‐Hsin Lan

4.9k total citations
129 papers, 3.7k citations indexed

About

Keng‐Hsin Lan is a scholar working on Hepatology, Oncology and Molecular Biology. According to data from OpenAlex, Keng‐Hsin Lan has authored 129 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hepatology, 35 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Keng‐Hsin Lan's work include Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (16 papers). Keng‐Hsin Lan is often cited by papers focused on Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (16 papers). Keng‐Hsin Lan collaborates with scholars based in Taiwan, United States and Japan. Keng‐Hsin Lan's co-authors include Masao Omata, Yasushi Shiratori, Naoya Kato, Ono S, Meei‐Ling Sheu, Richard R. Neubig, Yee Chao, Shou‐Dong Lee, Hideo Yoshida and Yi‐Hsiang Huang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Keng‐Hsin Lan

123 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keng‐Hsin Lan Taiwan 33 1.4k 1.2k 1.1k 753 517 129 3.7k
Bruno Sáinz Spain 39 2.0k 1.5× 620 0.5× 1.1k 1.0× 1.7k 2.3× 182 0.4× 88 4.7k
Jeffrey Teckman United States 38 1.7k 1.2× 468 0.4× 1.2k 1.0× 1.1k 1.4× 337 0.7× 113 4.3k
Hidekazu Nakabayashi Japan 21 1.4k 1.0× 629 0.5× 645 0.6× 468 0.6× 714 1.4× 39 2.7k
Wen Yang China 26 1.9k 1.4× 569 0.5× 516 0.5× 1.1k 1.4× 284 0.5× 71 3.7k
Nathalie Wong Hong Kong 46 4.6k 3.3× 843 0.7× 1.2k 1.0× 1.6k 2.1× 563 1.1× 120 7.4k
Takahiro Kodama Japan 39 2.4k 1.7× 884 0.7× 1.3k 1.1× 824 1.1× 264 0.5× 176 5.8k
Abdel‐Rahman N. Zekri Egypt 29 1.0k 0.7× 792 0.7× 832 0.7× 679 0.9× 155 0.3× 159 2.7k
Tomohide Tatsumi Japan 46 2.2k 1.6× 1.6k 1.4× 2.0k 1.7× 1.6k 2.1× 248 0.5× 185 6.9k
Владимир Субботин United States 35 1.0k 0.7× 786 0.7× 499 0.4× 297 0.4× 557 1.1× 108 3.4k
Michael J. Brunda United States 29 1.0k 0.7× 992 0.8× 1.2k 1.0× 1.6k 2.2× 737 1.4× 76 5.4k

Countries citing papers authored by Keng‐Hsin Lan

Since Specialization
Citations

This map shows the geographic impact of Keng‐Hsin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keng‐Hsin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keng‐Hsin Lan more than expected).

Fields of papers citing papers by Keng‐Hsin Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keng‐Hsin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keng‐Hsin Lan. The network helps show where Keng‐Hsin Lan may publish in the future.

Co-authorship network of co-authors of Keng‐Hsin Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Keng‐Hsin Lan. A scholar is included among the top collaborators of Keng‐Hsin Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keng‐Hsin Lan. Keng‐Hsin Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Yi‐Ping, Pei‐Chang Lee, Yen‐Hwa Chang, et al.. (2024). Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas. Alimentary Pharmacology & Therapeutics. 61(3). 501–512. 3 indexed citations
2.
Lee, I‐Cheng, Keng‐Hsin Lan, Chien‐Wei Su, et al.. (2022). Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy. International Journal of Molecular Sciences. 23(19). 11335–11335. 4 indexed citations
3.
Hsu, Fei‐Ting, et al.. (2022). Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine. 26(7). 1955–1968. 9 indexed citations
4.
Chen, Jenny Ling‐Yu, Chao‐Yuan Huang, Yu‐Sen Huang, et al.. (2021). Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer. Cancers. 13(6). 1386–1386. 1 indexed citations
5.
6.
Chen, Yu‐Hsuan, Chunwei Wang, Ming‐Feng Wei, et al.. (2019). Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer. Cancers. 11(8). 1204–1204. 10 indexed citations
7.
Wy, Chen, Chen‐Tu Wu, Chunwei Wang, et al.. (2018). Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer. Radiation Oncology. 13(1). 157–157. 27 indexed citations
8.
Lee, Wei‐Ping, Ming‐Chih Hou, Keng‐Hsin Lan, et al.. (2016). Helicobacter pylori-induced chronic inflammation causes telomere shortening of gastric mucosa by promoting PARP-1-mediated non-homologous end joining of DNA. Archives of Biochemistry and Biophysics. 606. 90–98. 23 indexed citations
9.
Lee, Wei‐Ping, Keng‐Hsin Lan, Chung‐Pin Li, et al.. (2016). Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 837–849. 3 indexed citations
10.
Lee, Wen‐Jane, Keng‐Hsin Lan, Chiang‐Ting Chou, et al.. (2013). Tpl2 Inhibitors Thwart Endothelial Cell Function in Angiogenesis and Peritoneal Dissemination. Neoplasia. 15(9). 1036–IN4. 26 indexed citations
11.
Liu, Shing‐Hwa, et al.. (2012). Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice. PLoS ONE. 7(8). e43711–e43711. 44 indexed citations
12.
Yang, Kailin, Pin‐I Huang, Tai‐Tong Wong, et al.. (2010). Long-Term Outcomes of Radiotherapy for Primary Pediatric Brain Tumors: Statistics and Strategies of a Single Institute in Taiwan. 17(2). 85–99. 3 indexed citations
13.
Lan, Keng‐Hsin, et al.. (2007). Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer. Clinical & Experimental Metastasis. 24(6). 461–470. 9 indexed citations
14.
Xu, Shisan, et al.. (2006). Real-time quantitative assay of HCV RNA using the duplex scorpion primer. Archives of Virology. 152(2). 431–440. 3 indexed citations
15.
Lan, Keng‐Hsin, Meei‐Ling Sheu, Shinn‐Jang Hwang, et al.. (2002). HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene. 21(31). 4801–4811. 186 indexed citations
16.
Hwang, Shinn‐Jang, et al.. (2002). Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens. 59(1). 31–37. 22 indexed citations
17.
Lan, Keng‐Hsin. (1999). Mechanism and specificity of G protein regulation by RGS proteins.. Deep Blue (University of Michigan). 3 indexed citations
18.
Ohashi, Makoto, Fumihiko Kanai, Torao Tanaka, et al.. (1998). In vivo Adenovirus‐mediated Prodrug Gene Therapy for Carcinoembryonic Antigen‐producing Pancreatic Cancer. Japanese Journal of Cancer Research. 89(4). 457–462. 19 indexed citations
19.
Ogura, K., Fumihiko Kanai, Shin Maeda, et al.. (1997). High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut. 41(4). 463–468. 37 indexed citations
20.
Lan, Keng‐Hsin, Fumihiko Kanai, Yasushi Shiratori, et al.. (1996). Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors. Gastroenterology. 111(5). 1241–1251. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Sáinz Breakdown of academic impact, for papers by Jeffrey Teckman Breakdown of academic impact, for papers by Hidekazu Nakabayashi Breakdown of academic impact, for papers by Wen Yang Breakdown of academic impact, for papers by Nathalie Wong Breakdown of academic impact, for papers by Takahiro Kodama Breakdown of academic impact, for papers by Abdel‐Rahman N. Zekri Breakdown of academic impact, for papers by Tomohide Tatsumi Breakdown of academic impact, for papers by Владимир Субботин Breakdown of academic impact, for papers by Michael J. Brunda
Rankless by CCL
2026